U UNI-QLEAVER Trademark

Trademark Overview


On Monday, September 2, 2019, a trademark application was filed for U UNI-QLEAVER with the United States Patent and Trademark Office. The USPTO has given the U UNI-QLEAVER trademark a serial number of 79271602. The federal status of this trademark filing is REGISTERED as of Tuesday, October 20, 2020. This trademark is owned by QuiaPEG Pharmaceuticals AB. The U UNI-QLEAVER trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances; PEGylation pharmaceuticals research services; industrial analysis and industrial research services in the field of pharmaceutical testing; product design, testing and development in the field of medical technology; information and advice regarding the aforementioned services

Chemicals for use in industry and science; biological preparations for use in industry and science; Reagents for scientific and research use, Diagnostic preparations for scientific or research use; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers

Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; reagents for medical and veterinary uses; pharmaceutical substances being diagnostic, preparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents, substances and contrast media for medical and veterinary purposes
u uni-qleaver

General Information


Serial Number79271602
Word MarkU UNI-QLEAVER
Filing DateMonday, September 2, 2019
Status700 - REGISTERED
Status DateTuesday, October 20, 2020
Registration Number6177161
Registration DateTuesday, October 20, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements


Indication of Colors claimedThe color(s) orange, light orange, blue, and white is/are claimed as a feature of the mark.
Goods and ServicesScientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances; PEGylation pharmaceuticals research services; industrial analysis and industrial research services in the field of pharmaceutical testing; product design, testing and development in the field of medical technology; information and advice regarding the aforementioned services
Description of MarkThe mark consists of the wording "UNI-QLEAVER" in blue and the design of an orange and light orange circle containing a white letter "U" inside of it.
Goods and ServicesChemicals for use in industry and science; biological preparations for use in industry and science; Reagents for scientific and research use, Diagnostic preparations for scientific or research use; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers
Goods and ServicesPharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; reagents for medical and veterinary uses; pharmaceutical substances being diagnostic, preparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents, substances and contrast media for medical and veterinary purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, November 15, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 15, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQuiaPEG Pharmaceuticals AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUppsala SE-754 50
SE

Party NameQuiaPEG Pharmaceuticals AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUppsala SE-754 50
SE

Party NameQuiaPEG Pharmaceuticals AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUppsala SE-754 50
SE

Trademark Events


Event DateEvent Description
Thursday, November 14, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, December 4, 2019ASSIGNED TO EXAMINER
Thursday, December 5, 2019NON-FINAL ACTION WRITTEN
Friday, December 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 31, 2019REFUSAL PROCESSED BY MPU
Wednesday, January 1, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 17, 2020REFUSAL PROCESSED BY IB
Thursday, May 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 26, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 26, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, May 26, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 26, 2020ASSIGNED TO LIE
Tuesday, May 26, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, July 1, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 1, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, July 1, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 1, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, July 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 15, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 15, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, July 31, 2020NOTIFICATION PROCESSED BY IB
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, January 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, February 3, 2021FINAL DISPOSITION PROCESSED
Wednesday, February 3, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 20, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED